Role of Droperidol in Postoperative Vomiting

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Protocol title: Role of low dose droperidol in postoperative vomiting

Purpose: Evaluate the efficacy of droperidol to postoperative nausea and vomiting when administrated at the introduction to anesthesia, prior to surgery

Design: Prospective, randomized, placebo-controlled study

Patient Population: Male or female subjects 18 years of age or older who are scheduled for laparoscopic cholecystectomy

No. of Subjects: 100 patients divided into two groups, estimated up to 6 months to enroll

Duration of Treatment: Prior operation

Duration of Follow-up: Follow-up will be performed for 24 hours postoperatively

Endpoints: To evaluate the effectiveness of low dose droperidol when administered Prior surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aristotle University Of Thessaloniki
• Collaborator: AHEPA University Hospital
• Treatments: Droperidol

Criteria

Inclusion Criteria:

• Patient more than 18 years old

• Patients scheduled for laparoscopic cholecystectomy

• Informed consent obtained from the patient

Exclusion Criteria:

• Age < 18 years old

• Contraindication to laparoscopic surgery

• Present a severe depressive syndrome

• Pregnancy women

• Trouble of cardiac rate

• Alcoholism

• Contra-indication for Droperidol prescription